Welcome to Alzheimer's Association TrialMatch, a free service that makes it easy for people with Alzheimer's, caregivers, families and physicians to locate clinical trials based on personal criteria (diagnosis, stage of disease) and location.
Right now, we are in the midst of an exciting time. More than 100 research studies pertaining to Alzheimer's disease and related dementias are underway and recruiting volunteers. Alzheimer's Association TrialMatch lets you search these trials quickly and easily. It also narrows results to those trials where there is a reasonable chance to be accepted for enrollment. This saves time for both you and the researcher. Enrolling the right participants helps researchers accurately measure the effect of a treatment.
Importance of clinical trials
Clinical trials are the engine that powers medical progress. Through clinical trials, researchers test new ways to detect, treat and prevent Alzheimer's disease and related dementias. Without clinical trials, there can be no new treatments or cures.
Over the last 15 years, scientists have made enormous strides in understanding how Alzheimer's disease affects the brain. Currently, the drugs available for the treatment of Alzheimer's only temporarily improve the symptoms of the disease; they do not stop the damage to brain cells that causes Alzheimer's to progress. But scientists believe that in the near future, therapies and treatments that slow or stop the progression of the disease will be available.
Ground-breaking research is going on that could have a measurable impact on the lives of current and Participation in clinical studies provides an opportunity to advance and accelerate medical research and to contribute to the better health of future generations. Use the Alzheimer's Association TrialMatch service above to find a clinical trial now.
The trial listings in the Alzheimer's Association TrialMatch come from publicly available sources, such as clincaltrials.gov from the National Institutes of Health. In addition, direct outreach is being made to a wide variety of research facilities and trial sites across the country to include their Alzheimer's/dementia studies in the database. In order to be included in Alzheimer's Association TrialMatch, trial sites must submit proof of their approval by an institutional review board (IRB). This is a committee that approves, monitors and reviews research involving humans to protect the rights and welfare of the research subjects. Then the trials go through additional vetting by the Alzheimer's Association prior to being listed to ensure that listings only include credible trials and investigators.
In addition to Alzheimer's Association TrialMatch, the following resources may be helpful in locating clinical trials:
If your IRB-approved trial or trial-site is not currently listed in Alzheimer's Association TrialMatch, and you would like to include it, please read our detailed instructions on how to submit a request. Next, fill out our request form and submit it to ALZTrialMatch@emergingmed.com. An EmergingMed representative will contact you within seven business days and notify you of the status of your request.